Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05943626 · ClinicalTrials.gov registry record · NA

Circadian Intervention to Improve Cardiometabolic Health

A NA study of Type 2 Diabetes and Sleep, sponsored by University of Utah.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05943626 is a NA study of Type 2 Diabetes and Sleep that is actively recruiting participants, run by University of Utah. The registered enrollment target is 20 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05943626, a NA study of Type 2 Diabetes and Sleep, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The overall goal is to examine the efficacy of a circadian intervention in people with overweight and obesity and habitual short sleep duration (HSSD). Participants will undergo a randomized controlled trial, with circadian intervention and control (healthy lifestyle) groups. The circadian intervention is designed to reduce nighttime light exposure and after-dinner snack food intake. Alternatively, the control group will receive basic health information (e.g., physical activity, goal setting, and nutrition when eating out).

Interventions

  • BEHAVIORAL Circadian Intervention

Study Locations (1)

Utah

  • College of Health Research Complex--University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-06-13
Est. Completion 2026-03
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT05943626

The ClinicalTrials.gov registry entry for NCT05943626 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Circadian Intervention is the first listed.

NCT05943626 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT05943626 about?

NCT05943626 is a clinical study titled "Circadian Intervention to Improve Cardiometabolic Health". The overall goal is to examine the efficacy of a circadian intervention in people with overweight and obesity and habitual short sleep duration (HSSD). Participants will undergo a randomized controlled trial, with circadian intervention and control (healthy lifestyle) groups. The circadian intervent...

What is the current status of trial NCT05943626?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-06-13. Estimated completion is 2026-03.

What conditions does trial NCT05943626 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Sleep, Overweight and Obesity, Insulin Sensitivity, Sleep Hygiene.

What interventions are being tested in trial NCT05943626?

The interventions under investigation include: Circadian Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05943626?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05943626 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.